Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer

BACKGROUND: Secondary cytoreductive surgery (SCS) is possible in selected patients with recurrent epithelial ovarian cancer (EOC). The goal of SCS is complete resection, although chemotherapy is always followed. Delayed intervals between primary debulking surgery and adjuvant chemotherapy was report...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Ovarian Res
Main Authors: Jeong, Soo Young, Choi, Chel Hun, Kim, Tae Joong, Lee, Jeong Won, Kim, Byoung-Gie, Bae, Duk Soo, Lee, Yoo-Young
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6937657/
https://ncbi.nlm.nih.gov/pubmed/31892329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-019-0602-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados